Clinical Trial Update: Pragmatic Optimized Rifampicin Trial [Phase 3]

View source ↗

Summary

This update highlights a Phase 3 pragmatic trial evaluating optimized rifampicin regimens for pulmonary tuberculosis, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Rifampicin

Snippet

Sponsor: Radboud University Medical Center | Conditions: Tuberculosis, Pulmonary | Phase 3 | Status: RECRUITING